Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades
Macquarie upgraded the previous rating for Netflix Inc (NASDAQ:NFLX) from Underperform to Neutral. Netflix earned $3.20 in the second quarter, compared to $2.97 in the year-ago quarter. At the moment, the stock has a 52-week-high of $609.99 and a 52-week-low of $162.71. Netflix closed at $218.39 at the end of the last trading period.
For Ryman Hospitality Properties Inc (NYSE:RHP), Truist Securities upgraded the previous rating of Hold to Buy. In the second quarter, Ryman Hospitality Props showed an EPS of $2.05, compared to $0.03 from the year-ago quarter. The current stock performance of Ryman Hospitality Props shows a 52-week-high of $101.19 and a 52-week-low of $70.47. Moreover, at the end of the last trading period, the closing price was at $80.45.
Wolfe Research upgraded the previous rating for Pinterest Inc (NYSE:PINS) from Peer Perform to Outperform. For the second quarter, Pinterest had an EPS of $0.11, compared to year-ago quarter EPS of $0.25. At the moment, the stock has a 52-week-high of $36.95 and a 52-week-low of $16.14. Pinterest closed at $22.10 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
B. Riley Securities downgraded the previous rating for ChannelAdvisor Corp (NYSE:ECOM) from Buy to Neutral. In the second quarter, ChannelAdvisor showed an EPS of $0.17, compared to $0.26 from the year-ago quarter. The stock has a 52-week-high of $24.92 and a 52-week-low of $11.89. At the end of the last trading period, ChannelAdvisor closed at $22.79.
According to Wolfe Research, the prior rating for Lions Gate Entertainment Corp (NYSE:LGF) was changed from Outperform to Peer Perform. Lions Gate Enter earned $0.23 in the first quarter, compared to $0.18 in the year-ago quarter.
UBS downgraded the previous rating for Signify Health Inc (NYSE:SGFY) from Buy to Neutral. Signify Health earned $0.85 in the second quarter, compared to $0.00 in the year-ago quarter. The current stock performance of Signify Health shows a 52-week-high of $29.88 and a 52-week-low of $10.70. Moreover, at the end of the last trading period, the closing price was at $29.10.
According to Keybanc, the prior rating for UiPath Inc (NYSE:PATH) was changed from Overweight to Sector Weight. UiPath earned $0.02 in the second quarter, compared to $0.01 in the year-ago quarter. The current stock performance of UiPath shows a 52-week-high of $44.13 and a 52-week-low of $13.66. Moreover, at the end of the last trading period, the closing price was at $15.59.
For UiPath Inc (NYSE:PATH), Mizuho downgraded the previous rating of Buy to Neutral. UiPath earned $0.02 in the second quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of $44.13 and a 52-week-low of $13.66. At the end of the last trading period, UiPath closed at $15.59.
According to Guggenheim, the prior rating for Signify Health Inc (NYSE:SGFY) was changed from Buy to Neutral. In the second quarter, Signify Health showed an EPS of $0.85, compared to $0.00 from the year-ago quarter. The current stock performance of Signify Health shows a 52-week-high of $29.88 and a 52-week-low of $10.70. Moreover, at the end of the last trading period, the closing price was at $29.10.
For GMS Inc (NYSE:GMS), Truist Securities downgraded the previous rating of Buy to Hold. GMS earned $2.43 in the first quarter, compared to $1.67 in the year-ago quarter. At the moment, the stock has a 52-week-high of $61.60 and a 52-week-low of $36.10. GMS closed at $45.67 at the end of the last trading period.
For ChannelAdvisor Corp (NYSE:ECOM), DA Davidson downgraded the previous rating of Buy to Neutral. In the second quarter, ChannelAdvisor showed an EPS of $0.17, compared to $0.26 from the year-ago quarter. The current stock performance of ChannelAdvisor shows a 52-week-high of $24.92 and a 52-week-low of $11.89. Moreover, at the end of the last trading period, the closing price was at $22.79.
According to Stephens & Co., the prior rating for Veritex Holdings Inc (NASDAQ:VBTX) was changed from Overweight to Equal-Weight. For the second quarter, Veritex Holdings had an EPS of $0.55, compared to year-ago quarter EPS of $0.60. At the moment, the stock has a 52-week-high of $43.33 and a 52-week-low of $26.99. Veritex Holdings closed at $29.00 at the end of the last trading period.
Barclays downgraded the previous rating for PolyPid Ltd (NASDAQ:PYPD) from Overweight to Equal-Weight. For the second quarter, PolyPid had an EPS of $0.61, compared to year-ago quarter EPS of $0.56. The current stock performance of PolyPid shows a 52-week-high of $6.90 and a 52-week-low of $1.12. Moreover, at the end of the last trading period, the closing price was at $1.15.
According to Morgan Stanley, the prior rating for UiPath Inc (NYSE:PATH) was changed from Overweight to Equal-Weight. For the second quarter, UiPath had an EPS of $0.02, compared to year-ago quarter EPS of $0.01. The current stock performance of UiPath shows a 52-week-high of $44.13 and a 52-week-low of $13.66. Moreover, at the end of the last trading period, the closing price was at $15.59.
According to Citigroup, the prior rating for Kingsoft Cloud Holdings Ltd (NASDAQ:KC) was changed from Buy to Neutral. Kingsoft Cloud Holdings earned $0.28 in the second quarter, compared to $0.16 in the year-ago quarter. The current stock performance of Kingsoft Cloud Holdings shows a 52-week-high of $15.69 and a 52-week-low of $2.39. Moreover, at the end of the last trading period, the closing price was at $2.53.
MKM Partners downgraded the previous rating for Electronic Arts Inc (NASDAQ:EA) from Buy to Neutral. Electronic Arts earned $0.47 in the first quarter, compared to $0.79 in the year-ago quarter. At the moment, the stock has a 52-week-high of $142.79 and a 52-week-low of $109.24. Electronic Arts closed at $124.73 at the end of the last trading period.
According to BTIG, the prior rating for Signify Health Inc (NYSE:SGFY) was changed from Buy to Neutral. In the second quarter, Signify Health showed an EPS of $0.85, compared to $0.00 from the year-ago quarter. The stock has a 52-week-high of $29.88 and a 52-week-low of $10.70. At the end of the last trading period, Signify Health closed at $29.10.
According to Needham, the prior rating for ChannelAdvisor Corp (NYSE:ECOM) was changed from Buy to Hold. ChannelAdvisor earned $0.17 in the second quarter, compared to $0.26 in the year-ago quarter. The stock has a 52-week-high of $24.92 and a 52-week-low of $11.89. At the end of the last trading period, ChannelAdvisor closed at $22.79.
See all analyst ratings downgrades.
Initiations
With an Overweight rating, Capital One initiated coverage on Fennec Pharmaceuticals Inc (NASDAQ:FENC). The price target seems to have been set at $11.00 for Fennec Pharmaceuticals. In the second quarter, Fennec Pharmaceuticals showed an EPS of $0.19, compared to $0.15 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.60 and a 52-week-low of $4.11. Fennec Pharmaceuticals closed at $7.35 at the end of the last trading period.
Capital One initiated coverage on Chimerix Inc (NASDAQ:CMRX) with an Overweight rating. The price target for Chimerix is set to $7.00. In the second quarter, Chimerix showed an EPS of $0.27, compared to $0.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.02 and a 52-week-low of $1.27. Chimerix closed at $2.08 at the end of the last trading period.
With a Hold rating, Truist Securities initiated coverage on Hims & Hers Health Inc (NYSE:HIMS). The price target seems to have been set at $7.00 for Hims & Hers Health. Hims & Hers Health earned $0.10 in the second quarter, compared to $0.05 in the year-ago quarter. The current stock performance of Hims & Hers Health shows a 52-week-high of $7.28 and a 52-week-low of $2.72. Moreover, at the end of the last trading period, the closing price was at $5.98.
Northland Capital Markets initiated coverage on Stem Inc (NYSE:STEM) with an Outperform rating. The price target for Stem is set to $24.00. Stem earned $0.21 in the second quarter, compared to $1.00 in the year-ago quarter. The stock has a 52-week-high of $19.75 and a 52-week-low of $5.72. At the end of the last trading period, Stem closed at $14.11.
With a Buy rating, Alliance Global Partners initiated coverage on Quoin Pharmaceuticals Ltd (NASDAQ:QNRX). The price target seems to have been set at $20.00 for Quoin Pharmaceuticals. Quoin Pharmaceuticals earned $3.24 in the second quarter, compared to $0.00 in the year-ago quarter. At the moment, the stock has a 52-week-high of $28.11 and a 52-week-low of $0.32. Quoin Pharmaceuticals closed at $3.32 at the end of the last trading period.
With a Neutral rating, Credit Suisse initiated coverage on Tritium DCFC Ltd (NASDAQ:DCFC). The price target seems to have been set at $8.00 for Tritium DCFC. At the moment, the stock has a 52-week-high of $19.75 and a 52-week-low of $5.43. Tritium DCFC closed at $6.84 at the end of the last trading period.
With an Outperform rating, Credit Suisse initiated coverage on Wallbox NV (NYSE:WBX). The price target seems to have been set at $14.00 for Wallbox. The stock has a 52-week-high of $17.60 and a 52-week-low of $8.01. At the end of the last trading period, Wallbox closed at $8.19.
Truist Securities initiated coverage on Accolade Inc (NASDAQ:ACCD) with a Buy rating. The price target for Accolade is set to $15.00. For the first quarter, Accolade had an EPS of $0.62, compared to year-ago quarter EPS of $0.84. At the moment, the stock has a 52-week-high of $27.74 and a 52-week-low of $4.61. Accolade closed at $9.70 at the end of the last trading period.
Truist Securities initiated coverage on Progyny Inc (NASDAQ:PGNY) with a Buy rating. The price target for Progyny is set to $56.00. In the second quarter, Progyny showed an EPS of $0.09, compared to $0.19 from the year-ago quarter. The stock has a 52-week-high of $53.10 and a 52-week-low of $25.67. At the end of the last trading period, Progyny closed at $38.14.
With a Buy rating, Ladenburg Thalmann initiated coverage on Bridgeline Digital Inc (NASDAQ:BLIN). The price target seems to have been set at $4.50 for Bridgeline Digital. In the third quarter, Bridgeline Digital showed an EPS of $0.02, compared to $0.46 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2.40 and a 52-week-low of $1.06. Bridgeline Digital closed at $1.37 at the end of the last trading period.
Truist Securities initiated coverage on R1 RCM Inc (NASDAQ:RCM) with a Buy rating. The price target for R1 RCM is set to $29.00. In the second quarter, R1 RCM showed an EPS of $0.07, compared to $0.06 from the year-ago quarter. At the moment, the stock has a 52-week-high of $27.86 and a 52-week-low of $18.73. R1 RCM closed at $20.56 at the end of the last trading period.
With a Hold rating, Truist Securities initiated coverage on Cano Health Inc (NYSE:CANO). The price target seems to have been set at $7.00 for Cano Health. In the second quarter, Cano Health showed an EPS of $0.03, compared to $0.03 from the year-ago quarter. The stock has a 52-week-high of $9.47 and a 52-week-low of $3.81. At the end of the last trading period, Cano Health closed at $5.88.
With a Hold rating, Truist Securities initiated coverage on Change Healthcare Inc (NASDAQ:CHNG). The price target seems to have been set at $27.75 for Change Healthcare. In the first quarter, Change Healthcare showed an EPS of $0.38, compared to $0.41 from the year-ago quarter. At the moment, the stock has a 52-week-high of $25.01 and a 52-week-low of $18.97. Change Healthcare closed at $24.86 at the end of the last trading period.
Truist Securities initiated coverage on CareMax Inc (NASDAQ:CMAX) with a Hold rating. The price target for CareMax is set to $7.50. In the second quarter, CareMax showed an EPS of $0.11, compared to $0.26 from the year-ago quarter. The stock has a 52-week-high of $9.23 and a 52-week-low of $3.45. At the end of the last trading period, CareMax closed at $6.41.
B of A Securities initiated coverage on Ameriprise Financial Inc (NYSE:AMP) with a Buy rating. The price target for Ameriprise Financial is set to $336.00. In the second quarter, Ameriprise Financial showed an EPS of $5.81, compared to $5.27 from the year-ago quarter. At the moment, the stock has a 52-week-high of $332.37 and a 52-week-low of $219.99. Ameriprise Financial closed at $268.49 at the end of the last trading period.
With a Hold rating, Truist Securities initiated coverage on Teladoc Health Inc (NYSE:TDOC). The price target seems to have been set at $35.00 for Teladoc Health. In the second quarter, Teladoc Health showed an EPS of $0.44, compared to $0.86 from the year-ago quarter. At the moment, the stock has a 52-week-high of $95.71 and a 52-week-low of $27.38. Teladoc Health closed at $29.03 at the end of the last trading period.
Truist Securities initiated coverage on Doximity Inc (NYSE:DOCS) with a Hold rating. The price target for Doximity is set to $35.00. In the first quarter, Doximity showed an EPS of $0.14, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $64.95 and a 52-week-low of $27.06. Doximity closed at $32.18 at the end of the last trading period.
B of A Securities initiated coverage on StepStone Group Inc (NASDAQ:STEP) with a Buy rating. The price target for StepStone Group is set to $42.00. In the first quarter, StepStone Group showed an EPS of $0.41, compared to $0.41 from the year-ago quarter. The current stock performance of StepStone Group shows a 52-week-high of $42.33 and a 52-week-low of $22.39. Moreover, at the end of the last trading period, the closing price was at $27.06.
With a Hold rating, Truist Securities initiated coverage on GoodRx Holdings Inc (NASDAQ:GDRX). The price target seems to have been set at $6.50 for GoodRx Holdings. For the second quarter, GoodRx Holdings had an EPS of $0.06, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $33.15 and a 52-week-low of $5.58. GoodRx Holdings closed at $5.90 at the end of the last trading period.
With a Hold rating, Truist Securities initiated coverage on NextGen Healthcare Inc (NASDAQ:NXGN). The price target seems to have been set at $20.00 for NextGen Healthcare. NextGen Healthcare earned $0.16 in the first quarter, compared to $0.25 in the year-ago quarter. At the moment, the stock has a 52-week-high of $21.87 and a 52-week-low of $16.13. NextGen Healthcare closed at $16.71 at the end of the last trading period.
With a Hold rating, Truist Securities initiated coverage on Signify Health Inc (NYSE:SGFY). The price target seems to have been set at $30.50 for Signify Health. For the second quarter, Signify Health had an EPS of $0.85, compared to year-ago quarter EPS of $0.00. The stock has a 52-week-high of $29.88 and a 52-week-low of $10.70. At the end of the last trading period, Signify Health closed at $29.10.
With a Sell rating, UBS initiated coverage on Medpace Holdings Inc (NASDAQ:MEDP). The price target seems to have been set at $142.00 for Medpace Hldgs. In the second quarter, Medpace Hldgs showed an EPS of $1.46, compared to $1.06 from the year-ago quarter. The current stock performance of Medpace Hldgs shows a 52-week-high of $219.22 and a 52-week-low of $126.94. Moreover, at the end of the last trading period, the closing price was at $145.13.
With a Neutral rating, B of A Securities initiated coverage on GCM Grosvenor Inc (NASDAQ:GCMG). The price target seems to have been set at $10.00 for GCM Grosvenor. GCM Grosvenor earned $0.12 in the second quarter, compared to $0.10 in the year-ago quarter. The current stock performance of GCM Grosvenor shows a 52-week-high of $11.10 and a 52-week-low of $6.26. Moreover, at the end of the last trading period, the closing price was at $7.86.
With a Hold rating, Truist Securities initiated coverage on American Well Corp (NYSE:AMWL). The price target seems to have been set at $5.00 for American Well. American Well earned $0.25 in the second quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $6.30 and a 52-week-low of $2.52. American Well closed at $4.33 at the end of the last trading period.
With a Neutral rating, UBS initiated coverage on Syneos Health Inc (NASDAQ:SYNH). The price target seems to have been set at $68.00 for Syneos Health. Syneos Health earned $1.25 in the second quarter, compared to $0.97 in the year-ago quarter. The current stock performance of Syneos Health shows a 52-week-high of $102.67 and a 52-week-low of $57.93. Moreover, at the end of the last trading period, the closing price was at $59.51.
UBS initiated coverage on Icon PLC (NASDAQ:ICLR) with a Buy rating. The price target for Icon is set to $270.00. For the second quarter, Icon had an EPS of $2.86, compared to year-ago quarter EPS of $2.12. At the moment, the stock has a 52-week-high of $312.28 and a 52-week-low of $196.34. Icon closed at $208.75 at the end of the last trading period.
With a Buy rating, HC Wainwright & Co. initiated coverage on ANI Pharmaceuticals Inc (NASDAQ:ANIP). The price target seems to have been set at $50.00 for ANI Pharmaceuticals. For the second quarter, ANI Pharmaceuticals had an EPS of $0.13, compared to year-ago quarter EPS of $0.67. The stock has a 52-week-high of $48.26 and a 52-week-low of $22.31. At the end of the last trading period, ANI Pharmaceuticals closed at $34.94.
Needham initiated coverage on Arcutis Biotherapeutics Inc (NASDAQ:ARQT) with a Buy rating. The price target for Arcutis Biotherapeutics is set to $46.00. Arcutis Biotherapeutics earned $1.31 in the second quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of $27.40 and a 52-week-low of $13.59. At the end of the last trading period, Arcutis Biotherapeutics closed at $21.08.
With a Buy rating, JonesTrading initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ:FUSN). The price target seems to have been set at $10.00 for Fusion Pharmaceuticals. Fusion Pharmaceuticals earned $0.44 in the second quarter, compared to $0.63 in the year-ago quarter. The stock has a 52-week-high of $8.73 and a 52-week-low of $1.99. At the end of the last trading period, Fusion Pharmaceuticals closed at $2.39.
JonesTrading initiated coverage on POINT Biopharma Global Inc (NASDAQ:PNT) with a Buy rating. The price target for POINT Biopharma Global is set to $22.00. In the second quarter, POINT Biopharma Global showed an EPS of $0.27, compared to $0.15 from the year-ago quarter. The current stock performance of POINT Biopharma Global shows a 52-week-high of $10.47 and a 52-week-low of $5.22. Moreover, at the end of the last trading period, the closing price was at $7.31.
Oppenheimer initiated coverage on Aquestive Therapeutics Inc (NASDAQ:AQST) with an Outperform rating. The price target for Aquestive Therapeutics is set to $8.50. For the second quarter, Aquestive Therapeutics had an EPS of $0.36, compared to year-ago quarter EPS of $0.33. The current stock performance of Aquestive Therapeutics shows a 52-week-high of $4.29 and a 52-week-low of $0.62. Moreover, at the end of the last trading period, the closing price was at $1.25.
With a Buy rating, Stifel initiated coverage on Ventyx Biosciences Inc (NASDAQ:VTYX). The price target seems to have been set at $45.00 for Ventyx Biosciences. In the second quarter, Ventyx Biosciences showed an EPS of $0.39, compared to $4.31 from the year-ago quarter. At the moment, the stock has a 52-week-high of $27.65 and a 52-week-low of $9.50. Ventyx Biosciences closed at $24.05 at the end of the last trading period.
Stifel initiated coverage on DICE Therapeutics Inc (NASDAQ:DICE) with a Buy rating. The price target for DICE Therapeutics is set to $37.00. The current stock performance of DICE Therapeutics shows a 52-week-high of $25.92 and a 52-week-low of $12.63. Moreover, at the end of the last trading period, the closing price was at $18.95.
With a Buy rating, Stifel initiated coverage on Morphic Holding Inc (NASDAQ:MORF). The price target seems to have been set at $44.00 for Morphic Holding. For the second quarter, Morphic Holding had an EPS of $0.68, compared to year-ago quarter EPS of $0.77. The current stock performance of Morphic Holding shows a 52-week-high of $52.34 and a 52-week-low of $19.23. Moreover, at the end of the last trading period, the closing price was at $27.69.
With an Outperform rating, Credit Suisse initiated coverage on ChargePoint Holdings Inc (NYSE:CHPT). The price target seems to have been set at $22.00 for ChargePoint Hldgs. ChargePoint Hldgs earned $0.18 in the second quarter, compared to $0.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $20.99 and a 52-week-low of $8.50. ChargePoint Hldgs closed at $14.75 at the end of the last trading period.
With a Equal-Weight rating, Morgan Stanley initiated coverage on Alvotech (NASDAQ:ALVO). The price target seems to have been set at $10.00 for Alvotech. NoneThe stock has a 52-week-high of $14.04 and a 52-week-low of $5.20. At the end of the last trading period, Alvotech closed at $7.20.
Jefferies initiated coverage on Red Rock Resorts Inc (NASDAQ:RRR) with a Buy rating. The price target for Red Rock Resorts is set to $50.00. In the second quarter, Red Rock Resorts showed an EPS of $0.26, compared to $1.12 from the year-ago quarter. The current stock performance of Red Rock Resorts shows a 52-week-high of $55.84 and a 52-week-low of $30.98. Moreover, at the end of the last trading period, the closing price was at $37.36.
